{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:17:16Z","timestamp":1792192636485,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2011,5,1]],"date-time":"2011-05-01T00:00:00Z","timestamp":1304208000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2011,5]]},"DOI":"10.1016\/j.yebeh.2011.02.023","type":"journal-article","created":{"date-parts":[[2011,5,8]],"date-time":"2011-05-08T08:37:56Z","timestamp":1304843876000},"page":"91-93","source":"Crossref","is-referenced-by-count":11,"title":["Moderate toxic effects following acute zonisamide overdose"],"prefix":"10.1016","volume":"21","author":[{"given":"Katharina E.","family":"Hofer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Trachsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Rauber-L\u00fcthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Kupferschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd A.","family":"Kullak-Ublick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Ceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2011.02.023_bb0005","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0920-1211(92)90087-A","article-title":"Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex","volume":"12","author":"Suzuki","year":"1992","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0010","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0006-8993(87)90168-5","article-title":"Zonisamide enhances slow sodium inactivation in Myxicola","volume":"413","author":"Schauf","year":"1987","journal-title":"Brain Res"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0015","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1038\/sj.bjp.0701941","article-title":"Interaction between Ca2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode","volume":"124","author":"Okada","year":"1998","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(03)00183-9","article-title":"Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures","volume":"116","author":"Ueda","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0025","doi-asserted-by":"crossref","DOI":"10.1111\/j.1747-0285.2009.00857.x","article-title":"Which carbonic anhydrases are targeted by the antiepileptic sulfonamides and sulfamates?","volume":"74","author":"De Simone","year":"2009","journal-title":"Chem Biol Drug Des"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0030","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/S0920-1211(98)00109-0","article-title":"Biphasic effects of zonisamide on serotonergic system in rat hippocampus","volume":"34","author":"Okada","year":"1999","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0035","doi-asserted-by":"crossref","first-page":"269","DOI":"10.2147\/nedt.2006.2.3.269","article-title":"Zonisamide: a review of experience and use in partial seizures","volume":"2","author":"Wilfong","year":"2006","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0040","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yebeh.2006.02.001","article-title":"Long-term efficacy and safety of monotherapy and adjunctive therapy with zonisamide","volume":"8","author":"Tosches","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0045","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1001\/jama.291.5.615","article-title":"The new antiepileptic drugs: clinical applications","volume":"291","author":"LaRoche","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0050","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/WNF.0b013e318170577f","article-title":"Zonisamide for migraine prophylaxis in patients refractory to topiramate","volume":"32","author":"Bermejo","year":"2009","journal-title":"Clin Neuropharm"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0055","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.0013-9580.2005.14704.x","article-title":"Dose-dependent safety and efficacy of zonisamide: a randomized, double-blind, placebo-controlled study in patients with refractory partial seizures","volume":"46","author":"Brodie","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0060","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1046\/j.1528-1157.2002.40001.x","article-title":"Risk factors for suicide in epilepsy: a case control study","volume":"43","author":"Nilsson","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0065","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.seizure.2004.02.005","article-title":"Safety of newer generation anti-epileptic drugs in non-accidental overdose: an Irish population study","volume":"14","author":"Sukumaran","year":"2005","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0070","first-page":"463","article-title":"Monitoring plasma concentrations of zonisamide and clonazepam in an epileptic attempting suicide by an overdose of the drugs","volume":"43","author":"Naito","year":"1988","journal-title":"Curr Ther Res"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0075","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.yebeh.2010.01.007","article-title":"Lacosamide intoxication in attempted suicide","volume":"17","author":"Bauer","year":"2010","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0080","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1111\/j.0013-9580.2004.30603.x","article-title":"Dialyzability of the antiepileptic drug zonisamide in patients undergoing hemodialysis","volume":"45","author":"Ijiri","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0085","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1528-1167.2007.00983.x","article-title":"Pharmacokinetics and drug interactions with zonisamide","volume":"48","author":"Sills","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0090","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1016\/j.clinthera.2009.06.012","article-title":"Bioequivalence of zonisamide orally dispersible tablet and immediate-release capsule formulations: results from two open-label, randomized-sequence, single-dose, two-period, two-treatment crossover studies in healthy male volunteers","volume":"31","author":"Van Maanen","year":"2009","journal-title":"Clin Therap"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0095","first-page":"172","article-title":"Single- and multiple-dose pharmacokinetics of zonisamide","volume":"37","author":"Buchanan","year":"1996","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1006\/ebeh.2002.0339","article-title":"Topiramate overdose: clinical and laboratory features","volume":"3","author":"Fakhoury","year":"2002","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0105","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jemermed.2008.03.032","article-title":"Emergent complications of the newer anticonvulsants","volume":"38","author":"Wade","year":"2010","journal-title":"J Emerg Med"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0110","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(05)80120-5","article-title":"Self-poisoning with lamotrigine","volume":"342","author":"Buckley","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/j.yebeh.2011.02.023_bb0115","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/j.1528-1157.1985.tb05408.x","article-title":"Zonisamide in epilepsy: a pilot study","volume":"26","author":"Wilensky","year":"1985","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011000795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505011000795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,2]],"date-time":"2018-12-02T18:24:08Z","timestamp":1543775048000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505011000795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,5]]}},"alternative-id":["S1525505011000795"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2011.02.023","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2011,5]]}}}